Home > Cashflow Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Cash Inflow / Outflow ₹-38 Cr₹389 Cr₹19 Cr₹255 Cr₹14 Cr

What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?

The latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS is ₹-38 Cr based on Mar2025 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2025₹-38 Cr
Mar2024₹389 Cr
Mar2023₹19 Cr
Mar2022₹255 Cr
Mar2021₹14 Cr

How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2025 ₹-38 Cr
Negative
Mar2024 ₹389 Cr
1,902.17
Mar2023 ₹19 Cr
-92.37
Mar2022 ₹255 Cr
1,695.19
Mar2021 ₹14 Cr -

Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹61,037.0 Cr 2.8% 2.2% 40.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

2.8%

2.2%

40.6%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses